Missing/wrong data?
Log in to edit
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
scientific article published on 20 July 2020
Author/s
author: Audrey Dunn Galvin, Jonathan O'B Hourihane, Antonella Muraro, George Du Toit
Work details
Publication date
July 20, 2020
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.